Performance analysis of Psyence Biomedical (PBM)
Annual Return
Since Jan 25, 2024, PBM has had an average annual return of -98.23%, underperforming the benchmark SPY, which returned +21.68% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.67% | -94.92% | -99.41% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -33.33% | -50.00% | +0% | -66.67% | |||||||||
| 2025 | -25.42% | -20.45% | -51.43% | -23.53% | +30.77% | +11.76% | -5.26% | -44.44% | +10% | +0% | -54.55% | -40.00% | -94.92% |
| 2024 | -62.84% | -69.11% | +107.32% | -21.09% | -16.61% | -60.03% | +96.81% | -30.52% | -75.58% | -31.10% | -33.33% | -38.54% | -99.41% |
Drawdown analysis of Psyence Biomedical (PBM)
The maximum drawdown for the PBM was -99.99%, occurring on Apr 16, 2026. This drawdown has not yet recovered.
The current PBM drawdown is -99.99%.
Since Jan 25, 2024 PBM has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jan 25, 2024 | 497 | Apr 16, 2026 | Ongoing | Ongoing | Ongoing |